03/26/2026 | Press release | Distributed by Public on 03/26/2026 15:30
Cravath represented the initial purchasers in connection with the $700 million 144A/Reg. S high-yield senior notes offering of The Chemours Company a leading, global provider of performance chemicals. The transaction closed on March 12, 2026.
The Cravath team included partner Craig F. Arcella and associates Trevor Lutzow and Gabriela Flores-Romo on capital markets matters, and partner Arvind Ravichandran and associate Ruth Goldstein Schapiro on tax matters. Yoojin Chae also worked on capital markets matters and Yasmeen Shrestha worked on tax matters.